USANA Health Sciences Inc's fundamentals are relatively very healthy, and its growth potential is significant.Its valuation is considered fairly valued, ranking 68/96 in the Food & Tobacco industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as , with the highest price target at 39.00.In the medium term, the stock price is expected to trend down.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
USANA Health Sciences Inc's Score
Industry at a Glance
Industry Ranking
68 / 96
Overall Ranking
372 / 4578
Industry
Food & Tobacco
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
0
analysts
--
Current Rating
39.000
Target Price
+100.93%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
USANA Health Sciences Inc Highlights
StrengthsRisks
USANA Health Sciences, Inc. and subsidiaries is a global nutrition, personal health and wellness company that develops and manufactures science-based nutritional and personal care products. Its segments include Direct selling and Hiya direct-to-consumer. The Direct Selling segment develops and manufactures science-based nutritional, personal care and skincare products with a primary focus on promoting long-term health and wellness in various geographic markets worldwide that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children’s health and wellness products in the United States that are distributed through the direct-to-consumer channel. Its product line includes USANA Nutritionals Optimizers, Essentials/CellSentials, and Foods. USANA Nutritionals Optimizers products include Proflavanol, CoQuinone 30, and BiOmega-3. Essentials/CellSentials products include USANA CellSentials and HealthPak 100.
Overvalued
The company’s latest PE is 21.71, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 11.27M shares, decreasing 1.22% quarter-over-quarter.
USANA Health Sciences, Inc. and subsidiaries is a global nutrition, personal health and wellness company that develops and manufactures science-based nutritional and personal care products. Its segments include Direct selling and Hiya direct-to-consumer. The Direct Selling segment develops and manufactures science-based nutritional, personal care and skincare products with a primary focus on promoting long-term health and wellness in various geographic markets worldwide that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children’s health and wellness products in the United States that are distributed through the direct-to-consumer channel. Its product line includes USANA Nutritionals Optimizers, Essentials/CellSentials, and Foods. USANA Nutritionals Optimizers products include Proflavanol, CoQuinone 30, and BiOmega-3. Essentials/CellSentials products include USANA CellSentials and HealthPak 100.
Ticker SymbolUSNA
CompanyUSANA Health Sciences Inc
CEOBrown (Jim H)
Websitehttps://www.usana.com/
FAQs
What is the current price of USANA Health Sciences Inc (USNA)?
The current price of USANA Health Sciences Inc (USNA) is 19.620.
What is the symbol of USANA Health Sciences Inc?
The ticker symbol of USANA Health Sciences Inc is USNA.
What is the 52-week high of USANA Health Sciences Inc?
The 52-week high of USANA Health Sciences Inc is 38.320.
What is the 52-week low of USANA Health Sciences Inc?
The 52-week low of USANA Health Sciences Inc is 18.480.
What is the market capitalization of USANA Health Sciences Inc?
The market capitalization of USANA Health Sciences Inc is 358.50M.
What is the net income of USANA Health Sciences Inc?
The net income of USANA Health Sciences Inc is 42.03M.
Is USANA Health Sciences Inc (USNA) currently rated as Buy, Hold, or Sell?
According to analysts, USANA Health Sciences Inc (USNA) has an overall rating of --, with a price target of 39.000.
What is the Earnings Per Share (EPS TTM) of USANA Health Sciences Inc (USNA)?
The Earnings Per Share (EPS TTM) of USANA Health Sciences Inc (USNA) is 0.907.